PRN: Global Market for Cell-Based Assays - Expected to Increase from $17.1 Billion in 2016 to Nearly $28.4 Billion in 2021

28/lug/2017 13:45:53 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Market for Cell-Based Assays - Expected to Increase from $17.1 Billion in 2016 to Nearly $28.4 Billion in 2021


DUBLIN, July 28, 2017 /PRNewswire/ --

The "Cell-based Assays: Technologies and Global Markets" report has been added to Research and Markets' offering.

Research and Markets Logo

This report is an update on the earlier report: Cell-based Assays: Technologies and Global Markets. It reviews global markets for cell-based assays and new developments and forecasts trends for use of these assays for drug discovery, safety and toxicology through 2021. The report includes important assays, technologies and the latest developments and market share by assay type and company, with a special emphasis on the U.S. market. Statistical information on the types of cancers prevalent worldwide is also included.

The report also includes current issues and trends affecting the industry, costs and factors influencing demand. It covers products in development, new technologies, trends, and alliances and mergers. The report offers market data by segment and region. It also provides market trends with respect to drivers, restraints and opportunities.

Report Includes

  • An overview of the global markets and related technologies for cell-based assays.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Examinations of major issues involved in the research and development (R&D) of more effective cell-based approaches, for drug discovery and absorption, distribution, metabolism, and excretion (ADME)/ toxicity assays in development and in use.
  • The current market status of cell-based assays in terms of strengths, weaknesses, opportunities and threats facing various assays and developments already on the market.
  • Discussion of current issues and trends affecting the industry, and costs and other factors influencing demand.
  • Coverage of new technologies, trends, alliances, and mergers.
  • Profiles of major players in the industry.

Companies Mentioned

  • Acea Biosciences
  • BD Biosciences
  • Beckman Coulter
  • Cellular Dynamics International
  • Caliper Life Sciences
  • Celsis In Vitro Technologies (Celsis Ivt)
  • Cisbio Bioassays
  • Discoverx Corp.
  • EMD Millipore
  • Enzo Life Sciences
  • Endonovo Therapeutics
  • Evotec AG
  • Ge Healthcare
  • Hemogenix
  • Life Technologies
  • Lonza
  • Molecular Devices (Danaher)
  • Oncolmmunin
  • Origene Technologies
  • Perkinelmer
  • Promega Corp.
  • Roche Group
  • Stemcells Inc.
  • Thermo Fisher Scientific
  • TTP Labtech
  • Vivo Biosciences
  • Vitro Biopharma

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Overview

4: Assays for Drug Discovery

5: Cell-based Assays: Current Technologies

6: Commercialization of Cell-based Assays

7: Global Cell-based Assay and Instrumentation Market

8: Global Regional Markets

9: Company Profiles

10: Legal Aspects of Cell-based Assays

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus è un servizio offerto da Factotum Srl